Nephros Inc (NEPH) stock
NEPHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3026% below fair value
$3.05−0.26 (-7.85%)
Close on Nov 13, 2026Market cap $33.12MP/E 16.9Yield –
Nephros price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Nephros's price to book ratio was 2.8× on Apr 30, 2024, against 2.6× a year earlier. Over the last 5 years it ranged from 1.0× to 163.7×, with a median of 5.8×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Apr 30, 2024 | 2.8× | −1.4 |
| 2023 | Dec 29, 2023 | 4.2× | +2.3 |
| 2022 | Dec 30, 2022 | 1.9× | −3.0 |
| 2021 | Dec 31, 2021 | 4.9× | −4.3 |
| 2020 | Dec 31, 2020 | 9.2× | −11.6 |
| 2019 | Dec 31, 2019 | 20.9× | +11.9 |
| 2018 | Dec 31, 2018 | 9.0× | −83.0 |
| 2017 | Dec 29, 2017 | 92.0× | +77.2 |
| 2016 | Dec 30, 2016 | 14.8× | +11.3 |
| 2015 | Dec 31, 2015 | 3.5× | −95.7 |
| 2014 | Oct 31, 2014 | 99.3× | +81.7 |
| 2013 | Dec 31, 2013 | 17.6× | −25.2 |
| 2012 | Dec 31, 2012 | 42.8× | +39.1 |
| 2011 | Dec 30, 2011 | 3.7× | – |
See a number that looks wrong?